People: PharMerica Corp (PMC.N)
PMC.N on New York Stock Exchange
14.79USD
1 Aug 2013
14.79USD
1 Aug 2013
Price Change (% chg)
$0.15 (+1.02%)
$0.15 (+1.02%)
Prev Close
$14.64
$14.64
Open
$14.73
$14.73
Day's High
$14.81
$14.81
Day's Low
$14.60
$14.60
Volume
40,975
40,975
Avg. Vol
69,219
69,219
52-wk High
$16.44
$16.44
52-wk Low
$9.85
$9.85
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Geoffrey Meyers |
68 | 2011 | Independent Chairman of the Board |
Gregory Weishar |
58 | 2007 | Chief Executive Officer, Director |
David Froesel |
61 | 2013 | Interim Chief Financial Officer |
Suresh Vishnubhatla |
44 | 2011 | Senior Vice President, Chief Technology Officer |
Berard Tomassetti |
57 | 2007 | Senior Vice President, Chief Accounting Officer |
Thomas Caneris |
50 | 2007 | Senior Vice President, Chief Compliance Officer, General Counsel, Secretary |
Mark Lindemoen |
46 | 2012 | Senior Vice President - Sales and Client Services |
Anthony Hernandez |
47 | 2007 | Senior Vice President - Human Resources |
Robert McKay |
51 | 2010 | Senior Vice President - Purchasing and Trade Relations |
Frank Collins |
59 | 2007 | Independent Director |
W.Robert Dahl |
56 | 2008 | Independent Director |
Marjorie Dorr |
51 | 2009 | Independent Director |
Thomas Gerrity |
71 | 2007 | Independent Director |
Patrick LePore |
58 | 2013 | Independent Director |
Thomas Mac Mahon |
66 | 2010 | Independent Director |
Robert Oakley |
66 | 2008 | Independent Director |
Moira Conlon |
IR Officer |
Biographies
| Name | Description |
|---|---|
Geoffrey Meyers |
Mr. Geoffrey G. Meyers is Independent Chairman of the Board of Pharmerica Corp. Mr. Meyers has served as a director since November 17, 2009 and as Chairman of the Board since January 1, 2011. Mr. Meyers is the retired Chief Financial Officer and Executive Vice President and Treasurer for Manor Care, Inc. where he had responsibility for administration and financial management from 1988 until 2006 and was a director of Health Care and Retirement Corp., a predecessor of Manor Care, Inc., from 1991 to 1998. Mr. Meyers has been a director of HCA Holdings, Inc. and Chairman of is audit committee since March 2011. Mr. Meyers is also the Chairman of the Board of the Trust Company of Toledo, a northwestern Ohio trust bank. He received his BA from Northwestern University and his MBA from The Ohio State University. |
Gregory Weishar |
Mr. Gregory S. Weishar is Chief Executive Officer, Director of PharMerica Corp., since January 14, 2007. He has 20 years experience in the pharmacy services industry. Prior to joining the Company, he was Chief Executive Officer and President of PharmaCare Management Services, a prescription benefit management firm and a wholly-owned subsidiary of CVS Corporation, from 1994. |
David Froesel |
Mr. David W. Froesel, Jr., has been appointed as Interim Chief Financial Officer of PharMerica Corporation effective April 12, 2013. A veteran of the health care industry, Mr. Froesel served for 14 years as Chief Financial Officer of Omnicare, Inc. At PharMerica, he will be responsible for the management of all finance related functions. He was Senior Vice President and Chief Financial Officer of Omnicare, Inc., from 1996 to 2009. Prior to that, he was Vice President, Finance & Administration and Corporate Controller of subsidiaries of Mallinckrodt Group, Inc., a $2.5 billion healthcare and specialty chemical company. He received a B.S. in Accounting from the University of Missouri-St. Louis and an M.S. in Accounting from St. Louis University, and he is a Certified Public Accountant. |
Suresh Vishnubhatla |
Mr. Suresh Vishnubhatla is Senior Vice President, Chief Technology Officer of Pharmerica Corp., since March 2011. Prior to joining the Company, he served as Senior Vice President and Chief Technology Officer of Millennium Pharmacy Systems, Inc. from January 2007. Prior to joining Millennium Pharmacy Systems, Inc., Mr. Vishnubhatla held positions with BodyMedia, Inc. from 2000 to 2006, finally serving as Senior Vice President, Products. |
Berard Tomassetti |
Mr. Berard E.Tomassetti is Senior Vice President, Chief Accounting Officer of PharMerica Corp., since July 2007. Prior to joining the Company, Mr. Tomassetti served as the Chief Financial Officer of the Kindred Healthcare, Inc. (“Kindred”) pharmacy business for over 6 years. Prior to joining Kindred’s pharmacy business, Mr. Tomassetti was affiliated with Aperture, a credentials verification organization. Mr. Tomassetti was an auditor with Ernst & Young LLP for 7 years. |
Thomas Caneris |
Mr. Thomas A. Caneris is Senior Vice President, Chief Compliance Officer, General Counsel, Secretary of Pharmerica Corp., since August 2007. Prior to joining the Company, Mr. Caneris served as counsel to Convergys Corporation from September 2004. Prior to that he was Commercial Affairs Counsel at AK Steel Corporation from April 1998 to September 2004. |
Mark Lindemoen |
Mr. Mark R. Lindemoen has been appointed as Senior Vice President of Sales and Client Services of Pharmerica Corp. Mr. Lindemoen was most recently Vice President of Sales for Gulf South Medical Supply in Jacksonville, Florida. Prior to Gulf South, Mr. Lindemoen was the Vice President, Regional Segment Sales Health Systems for AmerisourceBergen in Thorofare, New Jersey. Mr. Lindemoen previously served as a vice president for McKesson Medical Surgical and SCA Incontinence Care in Atlanta. |
Anthony Hernandez |
Mr. Anthony A. Hernandez is Senior Vice President - Human Resources of PharMerica Corp., since July 2007. Prior to joining the Company, Mr. Hernandez served as Senior Vice President of Human Resources for Citigroup’s Home Equity business. Mr. Hernandez was affiliated with Citigroup for 14 years. |
Robert McKay |
Mr. Robert A. McKay is Senior Vice President - Purchasing and Trade Relations of Pharmerica Corp., since July 2010. He had served as Senior Vice President of Sales and Marketing from July 2007 to June 2010. Prior to joining the Company in July 2007, Mr. McKay was Vice President of Marketing and Trade Relations for PharmaCare Management Services, a prescription benefit management firm and a wholly-owned subsidiary of CVS Corporation and held various positions with PharmaCare since 1995. Mr. McKay is a retired United States Army officer. |
Frank Collins |
Mr. Frank E. Collins, Esq., is Independent Director of Pharmerica Corp., since July 31, 2007. Mr. Collins was the Senior Vice President, Legal and Administration and Secretary of Sierra Health Services, Inc. (“Sierra”) from 2001 to February 2008. Sierra was acquired by United Health Group Incorporated (“United”) in February 2008. Mr. Collins now serves as the Deputy General Counsel of United. Mr. Collins joined Sierra in 1986 as General Counsel and Secretary. From 1981 to 1986, Mr. Collins was employed by Blue Cross and Blue Shield of Kansas City, originally as Staff Legal Counsel and in early 1986 as Associate General Counsel. Mr. Collins served as counsel for the Missouri Division of Insurance from 1979 to 1981, where he was responsible for providing legal advice on insurance and HMO-related regulatory issues. Mr. Collins received his Juris Doctor from the University of Missouri at Kansas City School of Law and is a member of the Missouri Bar Association. |
W.Robert Dahl |
Mr. W. Robert Dahl is Independent Director of PharMerica Corp., since July 24, 2008. Mr. Dahl is a private investor. He was the Chief Operating Officer of Arrowhawk Capital Partners, an investment company, from September 2009 until March 2012. Previously, from May 2007 to November 2009 he was the Vice President of Strategic Business Development and Vice Chairman of the Board of Directors of Golden Pond Healthcare, Inc. From April 1999 until June 2006, Mr. Dahl served as the head of Global Healthcare for the Carlyle Group, a private equity firm, where he was responsible for the firm’s investments in the healthcare field. Prior to Carlyle, Mr. Dahl served as co-head of healthcare investment banking in North America at Credit Suisse First Boston. Mr. Dahl is a director of Amkai LLC, Applied Science, Inc., Pharm Blue LLC and Sprout Pharmaceuticals, Inc., all of which are private companies. Mr. Dahl received a BA from Middlebury College and an MBA from the Harvard Graduate School of Business Administration. |
Marjorie Dorr |
Ms. Marjorie W. Dorr is Independent Director of Pharmerica Corp., since January 22, 2009. Ms. Dorr served as Executive Vice President and Chief Strategy Officer for WellPoint, Inc. from 2005 to 2007. Ms. Dorr held various executive positions while at WellPoint including President and Chief Executive Officer of WellPoint’s Northeast Region SBU, where she was responsible for operations in several states. Ms. Dorr joined WellPoint through the merger in 2004 of WellPoint and Anthem, Inc. At the time of the merger, Ms. Dorr served as President of Anthem Blue Cross and Blue Shield’s East region. Ms. Dorr received her bachelor of business administration degree from the University of Iowa and her master of business administration degree from the University of Chicago Graduate School of Business. |
Thomas Gerrity |
Dr. Thomas P. Gerrity, Ph.D., is Independent Director of PharMerica Corp., since July 31, 2007. Mr. Gerrity was the Dean of the Wharton School of the University of Pennsylvania from July 1990 to June 1999. Since then he has been Professor of Management and Dean Emeritus at the Wharton School of the University of Pennsylvania. Mr. Gerrity serves as a director of Internet Capital Group, Inc. and served as a member of the Corporation of the Massachusetts Institute of Technology from 2001-2011. Mr. Gerrity is the Chairman of the Board of Arden Fund I, a private real estate investment fund managed by the Arden Group in Philadelphia, Pennsylvania. Mr. Gerrity served as a director of Sunoco, Inc. from 1990 to May 2010. Mr. Gerrity served as a director of Federal National Mortgage Association (“Fannie Mae”) from September 1991 until December 2006. He was also a director of Knight-Ridder, Inc. from 1998 to 2006; CVS Corporation from 1995 to 2007; and Hercules, Inc. from 2003 to 2008. Mr. Gerrity served as Chief Executive Officer for 19 years at The Index Group, a in consulting to many corporations regarding IT strategy and overall corporate strategy and change management. |
Patrick LePore |
Mr. Patrick G. LePore has been appointed as Independent Director of PharMerica Corp. Since 2007, Mr. LePore has served as the Chairman of the Board of Par Pharmaceutical Companies, Inc., where he also served as Chief Executive Officer until the company's acquisition by private equity investor TPG in September 2012. Prior to joining Par Pharmaceutical, he was President of Cardinal Health, Inc.'s healthcare marketing group. Mr. LePore is a trustee of Villanova University, where he earned a B.A. degree. Mr. LePore earned his MBA degree from Fairleigh Dickinson University. |
Thomas Mac Mahon |
Mr. Thomas P. Mac Mahon is Independent Director of Pharmerica Corp. Between July 31, 2007 and December 31, 2010, Mr. Mac Mahon served as Chairman of the Board. Mr. Mac Mahon has served as a director of the Laboratory Corporation of America Holdings (“LabCorp”) since 1995. In addition, Mr. Mac Mahon served as a non-executive Chairman of the Board of LabCorp from January 2007 to May 2009; Executive Chairman of the Board from April 1996 to December 2006; and Vice-Chairman of the Board from April, 1995. From January 1997 until his retirement in December, 2006, Mr. Mac Mahon served as President and Chief Executive Officer and a member of the Executive and Management Committees of LabCorp. Mr. Mac Mahon was Senior Vice President or Hoffmann La Roche, Inc. from 1993 to December 1996 and President of Roche Diagnostics Group and a director and member of the Executive Committee of Hoffmann La Roche from 1988 to December 1996. Mr. Mac Mahon is a director and Corporate Governance Committee Chairperson of Express Scripts, Inc., was a director of Golden Pond Healthcare from November 2007 to November 2009, and is a member of the Board of SynapDx Corporation. Mr. Mac Mahon’s experience as a former Chief Executive Officer and Chairman of the Board, and as a board member at premier clinical laboratory and pharmacy. |
Robert Oakley |
Dr. Robert A. Oakley, Ph.D., is Independent Director of PharMerica Corp., since March 24, 2008. In 2003, Mr. Oakley retired after more than 25 years service with the Columbus, Ohio-based Nationwide Companies, one of the diversified insurance and financial services organizations in the world. Mr. Oakley served on the boards of Ohio Casualty Corporation from March 2003 to September 2008, First Mercury Financial Corporation from January 2008 to August 2009 and the Physicians Assurance Corporation from January 2008 to August 2009. He received his BS from Purdue University and both an MBA and Ph.D. in Finance from The Ohio State University. |
Moira Conlon |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Geoffrey Meyers |
-- |
Gregory Weishar |
3,914,000 |
David Froesel |
-- |
Suresh Vishnubhatla |
-- |
Berard Tomassetti |
-- |
Thomas Caneris |
1,006,170 |
Mark Lindemoen |
-- |
Anthony Hernandez |
657,533 |
Robert McKay |
835,306 |
Frank Collins |
-- |
W.Robert Dahl |
-- |
Marjorie Dorr |
-- |
Thomas Gerrity |
-- |
Patrick LePore |
-- |
Thomas Mac Mahon |
-- |
Robert Oakley |
-- |
Moira Conlon |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Geoffrey Meyers |
0 | 0 |
Gregory Weishar |
0 | 0 |
David Froesel |
0 | 0 |
Suresh Vishnubhatla |
0 | 0 |
Berard Tomassetti |
0 | 0 |
Thomas Caneris |
0 | 0 |
Mark Lindemoen |
0 | 0 |
Anthony Hernandez |
0 | 0 |
Robert McKay |
0 | 0 |
Frank Collins |
0 | 0 |
W.Robert Dahl |
0 | 0 |
Marjorie Dorr |
0 | 0 |
Thomas Gerrity |
0 | 0 |
Patrick LePore |
0 | 0 |
Thomas Mac Mahon |
0 | 0 |
Robert Oakley |
0 | 0 |
Moira Conlon |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
COLLINS FRANK E |
5,556 | $0.00 |
GERRITY THOMAS P |
5,556 | $0.00 |
MEYERS GEOFFREY G |
5,556 | $0.00 |
DAHL W ROBERT JR |
5,556 | $0.00 |
MAC MAHON THOMAS P |
5,556 | $0.00 |
OAKLEY ROBERT A |
5,556 | $0.00 |
LEPORE PATRICK G |
5,556 | $0.00 |
DORR MARJORIE W |
5,556 | $0.00 |
OAKLEY ROBERT A |
3,300 | $15.50 |
TOMASSETTI BERARD E |
9,724 | $15.68 |
TOMASSETTI BERARD E |
5,926 | $10.84 |
CANERIS THOMAS A |
1,548 | $14.03 |
CULOTTA MICHAEL J |
2,843 | $14.03 |
WEISHAR GREGORY S |
10,198 | $14.03 |
VISHNUBHATLA SURESH |
836 | $14.03 |
MCKAY ROBERT A |
1,321 | $14.03 |
HERNANDEZ ANTHONY A |
824 | $14.03 |
TOMASSETTI BERARD E |
464 | $14.03 |
MCKAY ROBERT A |
4,756 | $0.00 |
WEISHAR GREGORY S |
22,217 | $0.00 |
CANERIS THOMAS A |
5,630 | $0.00 |
CULOTTA MICHAEL J |
8,917 | $0.00 |
MCKAY ROBERT A |
1,727 | $14.48 |
CULOTTA MICHAEL J |
26,597 | $0.00 |
MCKAY ROBERT A |
11,405 | $0.00 |

